Michael Heltzen
Amministratore Delegato presso Invizyne Technologies, Inc.
Posizioni attive di Michael Heltzen
Società | Posizione | Inizio | Fine |
---|---|---|---|
Invizyne Technologies, Inc.
Invizyne Technologies, Inc. Chemicals: SpecialtyProcess Industries Invizyne Technologies, Inc. is a development stage synthetic biochemical company. Its synthetic biology platform would enable the scalable exploration of many molecules and properties found in nature. The company was founded by Tyler Korman and Paul Opgenorth in April 2019 and is headquartered in Monrovia, NV. | Amministratore Delegato | 01/02/2024 | - |
Corporate Officer/Principal | 01/10/2023 | 01/01/2024 | |
EXO INCUBATOR, INC.
EXO INCUBATOR, INC. BiotechnologyHealth Technology Exo Incubator, Inc. operates as a biotechnology firm that focuses on biomedical technology incubation and research. The private company is based in San Diego. | Presidente | 01/01/2015 | - |
Storia della carriera di Michael Heltzen
Precedenti posizioni note di Michael Heltzen
Società | Posizione | Inizio | Fine |
---|---|---|---|
Paragraf Ltd.
Paragraf Ltd. Electrical ProductsProducer Manufacturing Paragraf Ltd. operates as a graphene technology development firm. Its products include graphene layers, heterostructures, thin film material heterostructures, and graphene devices as well as novel 2D materials. The company was founded on November 25, 2015 and is headquartered in , the Cambridgeshire,United Kingdom. | Corporate Officer/Principal | 01/05/2023 | 01/10/2023 |
Cardea Bio, Inc.
Cardea Bio, Inc. BiotechnologyHealth Technology Cardea Bio, Inc. develops bioelectronics for use in research and diagnostics. Its products include AGILE 100 and pipeline. The company was founded by Ross Bundy, Kiana Aran, and Brett Goldsmith in 2013 and is headquartered in San Diego, CA. | Direttore/Membro del Consiglio | - | - |
Amministratore Delegato | 01/01/2019 | 01/05/2023 | |
CRISPRQC, Inc.
CRISPRQC, Inc. BiotechnologyHealth Technology CRISPRQC, Inc. provides a comprehensive crispr analytics platform that enables scientists and researchers to optimize gene editing outcomes and ensure the highest levels of quality control. The company is based in San Diego, CA. The platform is built on the company's proprietary crispr-chip technology, which allows for direct, real-time measurement of crispr activity. The company strives to empower its customers with the insights needed to push forward the life-saving cures and sustainable agricultural advances fueled by crispr editing. CRISPRQC was founded by Ross Bundy and Kiana Aran, with Ross Bundy serving as the CEO since incorporation. | Direttore/Membro del Consiglio | - | - |
Nanosens Innovations, Inc.
Nanosens Innovations, Inc. BiotechnologyHealth Technology Nanosens Innovations, Inc. develops bioelectronics for use in research and diagnostics. It sells CRISPR-Chip technology based products under the Nanosens brand. The company was founded by Kiana Aran and Michael Heltzen and is headquartered in San Diego, CA. | Amministratore Delegato | 01/12/2018 | 01/09/2019 |
Presidente | 01/12/2018 | 01/09/2019 | |
Fondatore | - | - |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Regno Unito | 2 |
Posizioni
Chairman | 3 |
Chief Executive Officer | 3 |
Director/Board Member | 2 |
Settori
Health Technology | 5 |
Process Industries | 2 |
Producer Manufacturing | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 6 |
---|---|
Cardea Bio, Inc.
Cardea Bio, Inc. BiotechnologyHealth Technology Cardea Bio, Inc. develops bioelectronics for use in research and diagnostics. Its products include AGILE 100 and pipeline. The company was founded by Ross Bundy, Kiana Aran, and Brett Goldsmith in 2013 and is headquartered in San Diego, CA. | Health Technology |
Nanosens Innovations, Inc.
Nanosens Innovations, Inc. BiotechnologyHealth Technology Nanosens Innovations, Inc. develops bioelectronics for use in research and diagnostics. It sells CRISPR-Chip technology based products under the Nanosens brand. The company was founded by Kiana Aran and Michael Heltzen and is headquartered in San Diego, CA. | Health Technology |
CRISPRQC, Inc.
CRISPRQC, Inc. BiotechnologyHealth Technology CRISPRQC, Inc. provides a comprehensive crispr analytics platform that enables scientists and researchers to optimize gene editing outcomes and ensure the highest levels of quality control. The company is based in San Diego, CA. The platform is built on the company's proprietary crispr-chip technology, which allows for direct, real-time measurement of crispr activity. The company strives to empower its customers with the insights needed to push forward the life-saving cures and sustainable agricultural advances fueled by crispr editing. CRISPRQC was founded by Ross Bundy and Kiana Aran, with Ross Bundy serving as the CEO since incorporation. | Health Technology |
Invizyne Technologies, Inc.
Invizyne Technologies, Inc. Chemicals: SpecialtyProcess Industries Invizyne Technologies, Inc. is a development stage synthetic biochemical company. Its synthetic biology platform would enable the scalable exploration of many molecules and properties found in nature. The company was founded by Tyler Korman and Paul Opgenorth in April 2019 and is headquartered in Monrovia, NV. | Process Industries |
Paragraf Ltd.
Paragraf Ltd. Electrical ProductsProducer Manufacturing Paragraf Ltd. operates as a graphene technology development firm. Its products include graphene layers, heterostructures, thin film material heterostructures, and graphene devices as well as novel 2D materials. The company was founded on November 25, 2015 and is headquartered in , the Cambridgeshire,United Kingdom. | Producer Manufacturing |
EXO INCUBATOR, INC.
EXO INCUBATOR, INC. BiotechnologyHealth Technology Exo Incubator, Inc. operates as a biotechnology firm that focuses on biomedical technology incubation and research. The private company is based in San Diego. | Health Technology |
- Borsa valori
- Insiders
- Michael Heltzen
- Esperienza